Clinical Trial: Research on the full process management strategy of off-label use of immune checkpoint inhibitors (China)

China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the full process management strategy of off-label use of immune checkpoint inhibitors'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135632

Registration Time: 2026/10/31

Type: Observational study

Primary Sponsor: Meishan City Peoples Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=286495

Published by HT Digital Content Services with permission from Health Daily Digest....